Literature DB >> 9609421

Inhaled nitric oxide in patients with pulmonary embolism.

J E Tulleken, T S van der Werf, J G Zijlstra, G Capellier, T Jacques, P Balvay, F Barale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9609421     DOI： 10.1007/pl00012682

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Oxygen desaturation after treatment with inhaled nitric oxide for obstructive shock due to massive pulmonary embolism.

Authors:  J E Tulleken; J G Zijlstra; K Evers; T S van der Werf
Journal:  Chest       Date:  1997-07       Impact factor: 9.410

2.  Inhaled nitric oxide selectively decreases pulmonary artery pressure and pulmonary vascular resistance following acute massive pulmonary microembolism in piglets.

Authors:  B W Böttiger; J Motsch; J Dörsam; U Mieck; A Gries; J Weimann; E Martin
Journal:  Chest       Date:  1996-10       Impact factor: 9.410

3.  Inhaled nitric oxide as an adjunct to pulmonary thromboendarterectomy.

Authors:  G Pinelli; P M Mertes; J P Carteaux; T Hubert; C Dopff; P Burtin; J P Villemot
Journal:  Ann Thorac Surg       Date:  1996-01       Impact factor: 4.330

4.  Use of inhaled nitric oxide to reverse flow through a patent foramen ovale during pulmonary embolism.

Authors:  P Estagnasié; G Le Bourdellès; L Mier; F Coste; D Dreyfuss
Journal:  Ann Intern Med       Date:  1994-05-01       Impact factor: 25.391

5.  Site of pulmonary vasodilation by inhaled nitric oxide in microembolic lung injury.

Authors:  C Mélot; F Vermeulen; M Maggiorini; E Gilbert; R Naeije
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

6.  Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs.

Authors:  A Gries; B W Böttiger; J Dörsam; H Bauer; J Weimann; C Bode; E Martin; J Motsch
Journal:  Anesthesiology       Date:  1997-02       Impact factor: 7.892

7.  Inhaled nitric oxide in patients with pulmonary embolism.

Authors:  G Capellier; T Jacques; P Balvay; G Blasco; E Belle; F Barale
Journal:  Intensive Care Med       Date:  1997-10       Impact factor: 17.440

8.  The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism.

Authors:  S A Webb; S Stott; P V van Heerden
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

9.  Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

Authors:  O Sitbon; F Brenot; A Denjean; A Bergeron; F Parent; R Azarian; P Herve; B Raffestin; G Simonneau
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

10.  Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease.

Authors:  J A Barberà; N Roger; J Roca; I Rovira; T W Higenbottam; R Rodriguez-Roisin
Journal:  Lancet       Date:  1996-02-17       Impact factor: 79.321
View more
  1 in total

1.  Increased expired NO and roles of CO2 and endogenous NO after venous gas embolism in rabbits.

Authors:  Per Agvald; L Christofer Adding; Kristofer F Nilsson; Lars E Gustafsson; Dag Linnarsson
Journal:  Eur J Appl Physiol       Date:  2006-04-21       Impact factor: 3.078
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.